Life sciences companies falling behind? – Healthcare Economist
That is what an analysis from PwC finds, at least…
Tag: healthcare
What is the PICOSI framework? – Healthcare Economist
When conducting evidence synthesis, many individuals use the PICO framework.…
Opioid deaths on the decline…but why? – Healthcare Economist
In the US, opioid abuse has become and epidemic. However,…
Healthcare organizations in the US may soon get a cybersecurity overhaul
A set of new requirements proposed by the US Department of Health and Human Services’…
Evolution of orphan drug – Healthcare Economist
A study by Fermaglich and Miller (2023) evaluated trends in…
Can we measure this? – Healthcare Economist
A paper by Kowal et al. (2023) does in fact measure the disparities in health…
How many patients are switching to biosimilars? – Healthcare Economist
That is a key question if long-run drug prices are…
Does NICE consider real-world data (RWD) for HTA evaluations? – Healthcare Economist
The answer is ‘yes’, but the question is in what manner? A paper by Che…
Health care in Spain – Healthcare Economist
ISPOR Europe kicks off this week in Barcelona, Spain. In…
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
Cost effectiveness analyses (CEA) aim to examine how a new health technologies impact health outcomes…